Thiamidol vs Hydroquinone for Melasma and Dark Spots

Thiamidol and hydroquinone both reduce pigment by inhibiting tyrosinase, the enzyme that makes melanin. The short answer: in a randomized trial, 0.2% Thiamidol improved melasma as much as 4% hydroquinone, with mild side effects, making it a reasonable option for people who don't tolerate hydroquinone. Hydroquinone remains a long-standing prescription standard in the US.

The head-to-head trial

In a randomized trial, global improvement scores showed improvement in 84% of participants using Thiamidol and 74% using hydroquinone; the authors concluded melasma improvement with 0.2% Thiamidol did not differ from 4% hydroquinone, and that Thiamidol can be considered for patients with poor tolerability or treatment failure with hydroquinone. Adverse effects with Thiamidol were mild, while two participants (8%) in the hydroquinone group had allergic contact dermatitis (Lima et al., J Eur Acad Dermatol Venereol, 2021).

Side-by-side

	Thiamidol	Hydroquinone
Type	Cosmetic tyrosinase inhibitor	Pigment-lightening drug
US availability	In cosmetic products	Prescription-only in the US
Typical use	Ongoing	Usually limited courses
Main side effects	Mild irritation	Irritation, allergic reactions; rare ochronosis with long-term use
Evidence	Newer, growing trials	Long history of use

How to use them

• Apply to affected areas as directed, usually once or twice daily.
• Use broad-spectrum sunscreen every day; without it, pigment returns (AAD: sunscreen FAQs).
• Expect 8 to 12 weeks for visible change.

Combination approaches

Dermatologists often combine lighteners with retinoids, azelaic acid or tranexamic acid. A meta-analysis found tranexamic acid reduced melasma severity, alone or added to routine therapy (Kim et al., Acta Derm Venereol, 2017).

Darker skin

Both can be used in darker skin. Avoid irritation, which can trigger post-inflammatory hyperpigmentation (Davis and Callender, J Clin Aesthet Dermatol, 2010).

Pregnancy

Ask your doctor before using either during pregnancy or breastfeeding.

More Thiamidol research

• Melasma split-face study: In a 12-week double-blind study, both Thiamidol and hydroquinone improved melasma scores, but Thiamidol improved them more; 79% of participants improved on the Thiamidol side versus 61% on the hydroquinone side. About 10% got worse on the hydroquinone side, and none on the Thiamidol side. Everyone used sunscreen (Arrowitz et al., J Invest Dermatol, 2019).
• Systematic review: A 2024 review of 14 clinical studies found all reported significant improvements in melasma, post-inflammatory hyperpigmentation, UV-induced dark spots or general facial hyperpigmentation. The typical regimen was 0.1% to 0.2% applied 2 to 4 times a day for 12 to 24 weeks. The authors still called the evidence limited and asked for more head-to-head trials against hydroquinone (Klein et al., J Drugs Dermatol, 2024).

Note that the studies differ: one trial found the two equal and another found Thiamidol better.

Frequently asked questions

Is Thiamidol safer than hydroquinone? It appears well tolerated, with less long-term safety concern, but it has a shorter track record.

Can I use both? Ask your dermatologist; switching to Thiamidol for maintenance is one approach.

Does Thiamidol work for sun spots? It's studied mainly for melasma and hyperpigmentation; lasers are more effective for distinct sun spots.

This article is for educational purposes only and is not medical advice. Talk to a board-certified dermatologist about your situation.

Sources

• Lima PB et al. Efficacy and safety of topical isobutylamido thiazolyl resorcinol (Thiamidol) vs 4% hydroquinone cream for melasma. J Eur Acad Dermatol Venereol. 2021. PubMed
• Kim HJ et al. Efficacy and safety of tranexamic acid in melasma: a meta-analysis. Acta Derm Venereol. 2017. PubMed
• Davis EC, Callender VD. Postinflammatory hyperpigmentation. J Clin Aesthet Dermatol. 2010. PubMed
• American Academy of Dermatology. Sunscreen FAQs